Holds one active US DMF for bivalirudin, filing since 2016. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds one active US DMF for bivalirudin, filing since 2018. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for bivalirudin, filing since 2012. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Holds one active US DMF for bivalirudin, filing since 2016.
Holds one active US DMF for bivalirudin, filing since 2010.
This page filters the worldwide Bivalirudin manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for bivalirudin and what filings they hold.
Chat with Fred, your AI analyst